Morgan Stanley’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.6M Sell
476,701
-14,500
-3% -$2.5M ﹤0.01% 1626
2025
Q4
$89.7M Buy
491,201
+81,621
+20% +$11.4M 0.01% 1545
2025
Q3
$49.7M Sell
409,580
-38,339
-9% -$4.32M ﹤0.01% 2011
2025
Q2
$46.8M Sell
447,919
-9,497
-2% -$1.01M ﹤0.01% 1986
2025
Q1
$53.3M Sell
457,416
-119,442
-21% -$13.6M ﹤0.01% 1759
2024
Q4
$48.8M Buy
576,858
+166,708
+41% +$15.3M ﹤0.01% 1852
2024
Q3
$36.9M Buy
410,150
+88,169
+27% +$7.7M ﹤0.01% 2151
2024
Q2
$25.9M Sell
321,981
-621,902
-66% -$46M ﹤0.01% 2387
2024
Q1
$75.3M Sell
943,883
-294,875
-24% -$24.8M 0.01% 1392
2023
Q4
$98.6M Buy
1,238,758
+940,337
+315% +$62.9M ﹤0.01% 1740
2023
Q3
$20.9M Sell
298,421
-24,896
-8% -$1.86M ﹤0.01% 2413
2023
Q2
$23.2M Sell
323,317
-124,455
-28% -$9.18M ﹤0.01% 2321
2023
Q1
$27.6M Sell
447,772
-29,484
-6% -$1.94M ﹤0.01% 2092
2022
Q4
$36.8M Sell
477,256
-122,275
-20% -$7.31M ﹤0.01% 1762
2022
Q3
$26.8M Buy
599,531
+207,545
+53% +$10.4M ﹤0.01% 1888
2022
Q2
$15M Buy
391,986
+161,074
+70% +$5.09M ﹤0.01% 2602
2022
Q1
$9.56M Buy
230,912
+54,016
+31% +$1.67M ﹤0.01% 2955
2021
Q4
$6.68M Sell
176,896
-189,073
-52% -$6.96M ﹤0.01% 3410
2021
Q3
$12.1M Buy
365,969
+48,523
+15% +$1.89M ﹤0.01% 2671
2021
Q2
$21.4M Buy
317,446
+174,980
+123% +$10.5M ﹤0.01% 2070
2021
Q1
$8.07M Buy
142,466
+93,505
+191% +$6.58M ﹤0.01% 2875
2020
Q4
$3.99M Buy
48,961
+6,786
+16% +$507K ﹤0.01% 3501
2020
Q3
$3M Sell
42,175
-3,304
-7% -$257K ﹤0.01% 3255
2020
Q2
$3.74M Sell
45,479
-46,252
-50% -$3.56M ﹤0.01% 2969
2020
Q1
$5.4M Buy
91,731
+35,379
+63% +$2.88M ﹤0.01% 2392
2019
Q4
$5.82M Sell
56,352
-35,890
-39% -$1.45M ﹤0.01% 3028
2019
Q3
$1.87M Buy
92,242
+71,356
+342% +$1.83M ﹤0.01% 3859
2019
Q2
$537K Sell
20,886
-69,797
-77% -$1.4M ﹤0.01% 4576
2019
Q1
$1.29M Buy
90,683
+84,636
+1,400% +$786K ﹤0.01% 3935
2018
Q4
$17K Sell
6,047
-963
-14% -$3.17K ﹤0.01% 6044
2018
Q3
$24K Sell
7,010
-2,000
-22% -$5.93K ﹤0.01% 6081
2018
Q2
$29K Hold
9,010
﹤0.01% 6050
2018
Q1
$22K Buy
9,010
+3,100
+52% +$9.28K ﹤0.01% 6105
2017
Q4
$33K Buy
5,910
+1,900
+47% +$9.59K ﹤0.01% 5951
2017
Q3
$22K Sell
4,010
-463
-10% -$2.48K ﹤0.01% 5993
2017
Q2
$25K Sell
4,473
-12,830
-74% -$53.7K ﹤0.01% 6038
2017
Q1
$67K Sell
17,303
-32,855
-66% -$157K ﹤0.01% 5743
2016
Q4
$338K Buy
50,158
+28,327
+130% +$199K ﹤0.01% 5127
2016
Q3
$172K Sell
21,831
-37,786
-63% -$286K ﹤0.01% 5079
2016
Q2
$449K Buy
59,617
+39,944
+203% +$368K ﹤0.01% 4493
2016
Q1
$170K Buy
19,673
+12,803
+186% +$117K ﹤0.01% 5071
2015
Q4
$64K Buy
+6,870
New +$60.5K ﹤0.01% 5616

Other funds holding AXSM